SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending downwards as investors digest recent news, potentially related to spending and debt concerns. The community is actively debating whether the dip presents a buying opportunity or if further declines are expected, with some suggesting market manipulation. Discussions include contrasting META's valuation and growth prospects with other tech giants.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal ($PYPL) is trending due to a mix of reactions to its recent earnings, partnership with OpenAI, and introduction of a dividend, with community chatter focusing on whether the stock is undervalued or being manipulated by large funds. Some traders are betting on a short squeeze, while others express frustration with the stock's inability to sustain gains despite positive news. The community is closely watching key levels and potential catalysts, including upcoming dividend dates and analyst ratings.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

GSAT is trending amid speculation of a potential acquisition, with SpaceX named as a possible suitor. Community discussions revolve around the implications of a buyout and potential bidding wars involving major players like Amazon and Apple, focusing on the value of GSAT's spectrum and its existing partnerships. Some investors believe a deal is imminent, while others highlight the company's fundamentals and potential for growth as an independent entity.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors discuss its potential, fueled by strong revenue growth from IBSRELA and anticipation for upcoming earnings; the community is weighing whether the stock is poised for a breakout or further consolidation. Some are focused on potential partnerships and acquisitions, while others highlight concerns around CMS reimbursement and debate the company's valuation relative to its peers. Technical analysis and sentiment about management's strategy further contribute to the discussions.

"Shina Inu is a decentralized meme token on the Ethereum blockchain. Its mission is to give back to the crypto community, give to charity, and win the heart of the greatest token of all time, Shiba Inu!   Shina Token is a very fun meme token project that has sold many rare and beautiful NFTs. NFT sales are used to support the team and provide upcoming features such as exclusive access to events and rewards that will soon be announced."

Shina Inu

Shina Inu is trending as the community notes ongoing accumulation and a constructive chart, anticipating a potential breakout. Discussions highlight strong support levels and steady buying pressure, suggesting a bullish outlook despite the current calm. Some users are pointing to a "CBM" event as a potential catalyst.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending as community members digest the latest earnings report, specifically highlighting the strength of Amazon Web Services (AWS). Discussions revolve around AWS's growth and its potential impact on the company's future, as well as partnerships with companies like AITX. Overall sentiment appears bullish with many analysts raising price targets.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending as the community speculates about a potential buyout and anticipates upcoming earnings, with some expressing frustration over a recent negative opinion impacting the stock price. Investors are closely watching for news on patent extensions and AUR200 developments, while also discussing the company's management and long-term strategy. Some traders mentioned the possibility of a short squeeze.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending, with community members speculating about the reasons behind the increased interest and potential catalysts, including government support for Canadian businesses. Discussions revolve around QNX technology, potential partnerships, and the possibility of a short squeeze, with some expressing bullish sentiment and anticipating significant growth for the company. There is also increasing chatter around cybersecurity and BlackBerry's role in secure communication solutions.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the Platform and Devices segments. The Platform segment includes digital advertising and related services including the demand-side platform and content distribution services such as subscription and transaction revenue shares, media and entertainment promotional spending, the sale of premium subscriptions, and the sale of branded channel buttons on remote controls. The Devices segment is involved in the sale of streaming players, audio products, smart home products, and accessories that are sold through retailers and distributors, as well as directly to customers through the company’s website. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku's stock is experiencing volatility as investors debate the implications of recent earnings, particularly the weakness in the device segment despite overall revenue growth. The community is focused on whether key price levels will hold and speculating about potential takeover scenarios. Broader market conditions and sector-specific news are also influencing the stock's movement.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Galectin Therapeutics is trending as the community discusses its potential for a buyout, especially with upcoming presentations at a liver disease conference (AASLD) in November and a targeted FDA meeting. Community members speculate on the drug's unique position in treating a specific stage of liver disease (MASH cirrhosis) with no direct competitors and a potential short squeeze scenario. There is also excitement around potential data from Nordic Biosciences that may strengthen the case for FDA approval or a buyout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MRK Dead $$ move on 
All biotech and medical device are dead

StockTwits for iOS

Merck & Co Inc

 Dead $$ move on 
All biotech and medical device are dead